Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

• Status: Completed
• Trial end date: 2021-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin plus sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH)after vaginal delivery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Aswan University Hospital
• Treatments: Carbetocin; Misoprostol; Oxytocin

Criteria

Inclusion Criteria:

• All participants had PPH defined as vaginal bleeding>500 ml after vaginal delivery and uterine atony confirmed by abdominal palpation

Exclusion Criteria:

• gestational age<37 weeks,

• genital tract trauma,

• coagulation defect,

• women with hypertension, preeclampsia, cardiac, renal or liver diseases, epilepsy

• known hypersensitivity to carbetocin or oxytocin.